We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
An award-wining organic snack and baking company focusing on allergy-free foods that only contain natural sugars and are suitable for vegans. Creative Nature's products are available in more than 3,500 stores in the UK, as well as online and worldwide in 11 countries. Over the next 12 months, the business intends to provide an online subscription model to generate greater website revenue and to increase production across their product range.
days to go: Expired investment: £503,232
MACACHA has designed natural protein shakes that have the nourishing power of plants, no artificial ingredients and have a positive impact on the environment, as well as looking beautiful on the kitchen counter!
days to go: Expired investment: £98,378
Howsy is a property management app that aims to make renting a satisfactory experience for landlords and tenants. The company claims to have created a digital ecosystem that removes traditional agents, bringing down the cost of managing a property by an estimated 75% and delivering satisfactory customer service. Howsy has 7,000 properties on its platform mixed between recurring revenue and one-off customers. It has also acquired two of the largest online agents in the UK, Upad and Happy Tenant Company, in December 2019 and September 2020, respectively. Howsy asserts that it has achieved a 130% year-on-year revenue growth despite the COVID-19 pandemic and has featured in press entities like Forbes, The Guardian, TechCityNews, and Startups.co.uk, amongst others. It will use the investment for working capital allocation across marketing, general/admin, and technology. It will also use the funds to provide a stable runway to its Series A funding round, which it hopes to complete by January 2022.
days to go: Expired investment: £824,280
A decentralised banking platform with already more than £13.5m dedicated for software development. BABB intends to become a licensed bank in the UK and is raising funds for the capital required to do so. The company aims to allow anyone access to a bank account, as well as a mobile app for customers to make payments, lend money and exchange currencies.

Pitch Rated

66%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £1,362,430
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph